Winner: The grant winner will receive 100,000 bp of DNA provided as gBlocks® Gene Fragments* (or the equivalent value in other products, including Megamer™ Single-Stranded Gene Fragments, custom Gene or MiniGene™ Synthesis products,
and Alt-R® CRISPR genome editing products), highlights through IDT’s communication channels, and a feature video about their winning business plan.
A runner up will be granted 50,000 bp of DNA provided as gBlocks Gene Fragments* (or the equivalent value in other products, including Megamer Single-Stranded Gene Fragments, custom Gene or MiniGene Synthesis products, and Alt-R CRISPR genome editing
The application deadline has passed, and WE ARE NO LONGER ACCEPTING NEW SUBMISSIONS
August 1, 2018
The grant is open to US-based organizations that have been in business for less than 5 years, have fewer than 50 employees, and have not completed any fundraising beyond Series A. Additionally, academic scientists with a business plan in place to launch
a company within the next two years may apply. Products from IDT must be an essential component of the company’s business plan. The company’s plan must be in the field of human health, sustainable manufacturing, or humanitarian causes.
Applicants must grant IDT the ability to use any materials received by IDT during the grant program for sales and marketing purposes. Applicants must be granted the authority by their organization to agree to this condition. Applicants agree to comply
with all applicable laws, statutes, ordinances, and regulations regarding applicant’s grant proposal. The grant award offer is void where prohibited. IDT reserves the right to limit or cancel the grant program at IDT’s discretion. IDT
account registration is required.
Applications must be submitted on this webpage. Use presentation format, 3 slides in length, and including the following information:
- Slide 1: Describe the company’s vision and objectives
- Slide 2: Describe how the company will benefit from the grant
- Slide 3: Describe how the company will impact the world in one of the three specified fields
- Impact/benefit to humanity
- Feasibility (technical and commercial)
- Must include use of gBlocks® Gene Fragments, Megamer Single-Stranded Gene Fragments, Custom Genes or MiniGene Synthesis products, or Alt-R® CRISPR products
- Small bonus will be given to applicants from the state of Iowa
Winners will be directly notified in September, and will be publicly announced in early November.
Grant program rules
Please read detailed contest rules for more information.
For questions, please contact us at firstname.lastname@example.org.
* The awards are calculated based on purchasing 1000 bp gBlocks® Gene Fragments; selecting other products may reduce the total number of bases below the described 100,000 or 50,000 bp awards. See rules for details.